CAS 1997387-43-5: N-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-N′-[(1S)-1-methyl-2-(3-thienyl)ethyl]urea
Formula:C19H27N3O2S
InChI:InChI=1S/C19H27N3O2S/c1-14(10-16-8-9-25-13-16)21-19(24)20-12-17(22(2)3)11-15-4-6-18(23)7-5-15/h4-9,13-14,17,23H,10-12H2,1-3H3,(H2,20,21,24)/t14-,17-/m0/s1
InChI key:InChIKey=MEDBIJOVZJEMBI-YOEHRIQHSA-N
SMILES:O=C(NCC(N(C)C)CC1=CC=C(O)C=C1)NC(C)CC2=CSC=C2
- Synonyms:
- 1-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)1-(thiophen-3-yl)propan-2-yl]urea
- N-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-N′-[(1S)-1-methyl-2-(3-thienyl)ethyl]urea
- PZM 21
- Urea, N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N′-[(1S)-1-methyl-2-(3-thienyl)ethyl]-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | PZM21 REF: IN-DA01EOCDCAS: 1997387-43-5 | 98% | 281.00 €~629.00 € | Fri 07 Mar 25 |
![]() | PZM21 REF: TM-T4386CAS: 1997387-43-5 | 99.59% | 47.00 €~472.00 € | Fri 14 Mar 25 |
![]() | PZM 21 REF: 3D-BP167100CAS: 1997387-43-5 | Min. 95% | 348.00 €~823.00 € | Mon 21 Apr 25 |

PZM21
CAS:1997387-43-5
PZM21 is an effective and selective μ opioid receptor agonist (EC50: 1.8 nM).
Formula:
C19H27N3O2S
Purity:
99.59%
Color and Shape:
Solid
Molecular weight:
361.5
Ref: TM-T4386
1mg | 47.00 € | ||
2mg | 60.00 € | ||
5mg | 87.00 € | ||
10mg | 127.00 € | ||
25mg | 205.00 € | ||
50mg | 298.00 € | ||
100mg | 472.00 € | ||
1mL*10mM (DMSO) | 97.00 € |
Estimated delivery in United States, on Friday 14 Mar 2025

PZM 21
CAS:1997387-43-5
Biased agonist of ?-opioid receptor ?OR; anti-pain agent with reduced addictivity
Formula:
C19H27N3O2S
Purity:
Min. 95%
Molecular weight:
361.5 g/mol
Ref: 3D-BP167100
10mg | 348.00 € | ||
50mg | 823.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025